306392
Human rights impact assessments: Documementing how private sector investments impact international health
This presentation will begin with an overview of the UN Guiding Principles for Business and Human Rights and their applicability to global public health advocacy. It will then explore the COBHRA tool, going through all phases of conducting a rights assessment, from how to form a research team, to data collection and analysis, to monitoring and company engagement.
The presentation will then highlight two COBHRA case studies and how they exposed serious community health concerns. The first assessed the rights of migrant and undocumented tobacco pickers in North Carolina, who faced pesticide poisoning, heatstroke and repetitive stress injuries. The second measured the impact of foreign investment in Bolivia’s hydrocarbon sector, and the environmental health impacts on Guarani indigenous communities. The presentation will end with an outline of how this tool can be used by public health advocates increase the ability of communities to articulate their rights and engage with companies, investors and government from a place of knowledge and power.
Learning Areas:
Advocacy for health and health educationPublic health or related research
Learning Objectives:
Discuss how the UN Guiding Principles on Business and Human Rights can be used by global health advocates
Describe how to use the Community-based Human Rights Impact Assessment tool
Explain how the tool has been used in the US and globally to document the human rights and health impacts of private sector activities, including agriculture and mining
Keyword(s): Advocacy, International Health
Qualified on the content I am responsible for because: I an senior policy advisor at Oxfam America, which has pioneered Community Based Human Rights Assessments, and have worked in the field of human rights, conflict and development for more than a decade.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.